US Corporate Distress Financial Stress SEC Filings — June 22, 2026

22-06-2026

Exyn Technologies entered into a Confidential Side Letter Agreement with Evergreen Capital Management on May 18, 2026, to resolve a potential default under the Second Amendment to the Note and Warrant Purchase Agreement. The agreement requires Exyn to file a resale registration statement within 30 days of its IPO closing (May 18, 2026), issue 100,000 additional shares to the lender, and repay the outstanding balance plus a default penalty in three monthly installments. In exchange, the lender withdrew a demand letter for $1,417,165 and agreed to forbear from declaring a default, while the company avoided liquidated damages and additional penalties.

• · The Side Letter was approved by Exyn's Board of Directors and executed on May 17, 2026, one day before the IPO closing.
• · The lender withdrew a demand letter that included assertions of default, liquidated damages, Default Rate interest, and attorneys' fees.
• · The Side Letter governs over conflicting terms in the Second Amendment, First Amendment, Purchase Agreement, Notes, and other Transaction Documents.
• · The agreement is governed by Nevada law, consistent with the underlying transaction documents.
• · The Side Letter is confidential, with limited exceptions for disclosure.

22-06-2026

CervoMed Inc. announced a $10 million registered direct offering of 2,500,000 shares of common stock at $4.00 per share, priced at-the-market under Nasdaq rules, with H.C. Wainwright & Co. as exclusive placement agent. The offering is expected to close on or about June 22, 2026, and net proceeds will be used for working capital and general corporate purposes. However, the company faces significant risks, including the need for additional financing and a partnership to initiate a Phase 3 trial for its lead drug candidate neflamapimod in dementia with Lewy bodies, and its ability to continue as a going concern is uncertain.

• · The offering is made under a shelf registration statement on Form S-3 (File No. 333-282494) declared effective on October 10, 2024.
• · CervoMed announced alignment with the FDA on a potential registration path for neflamapimod in DLB in November 2025.
• · Initiation of a Phase 3 trial in DLB is subject to the establishment of a partnership and/or additional financing.
• · Interim biomarker data from the Phase 2a trial in nonfluent variant primary progressive aphasia is anticipated in early Q4 2026.
• · The company's ability to continue as a going concern is explicitly listed as a risk factor.

22-06-2026

Strawberry Fields REIT, Inc. (STRW) closed on its previously announced Corporate Credit Facility (CCF) on June 18, 2026, with total availability of up to $300 million. The facility consists of a $100 million term loan and a $200 million revolving credit facility, both with Popular Bank as administrative agent and lender, and both maturing on June 18, 2029 with two one-year extension options. Proceeds will be used to refinance existing secured bank debt, support acquisition growth, working capital, and general corporate purposes.

• · The Term Loan bears interest at the greater of (i) 1-month CME Term SOFR + 275 bps or (ii) 5.50%.
• · The Revolving Loan bears interest at the greater of (i) 1-month CME Term SOFR + 275 bps or (ii) 5.50%.
• · Both loans are secured by a continuing security interest in a portion of SFRLP's assets and guaranteed by the Company and certain real estate subsidiaries.
• · The Term Loan matures on June 18, 2029; the Revolving Loan matures on June 18, 2029.
• · The Company is an emerging growth company (EGC) as defined under Rule 405 of the Securities Act.
• · The registrant has elected not to use the extended transition period for complying with new or revised financial accounting standards (Section 13(a) of the Exchange Act).

22-06-2026

CRH announced a definitive agreement to acquire Arcosa, Inc. for $150 per share in an all-cash transaction valued at approximately $8.5 billion enterprise value, representing an 11.5x multiple on 2026E Adjusted EBITDA. The acquisition is expected to be accretive to earnings, margin, and cash flow within the first 12 months post-completion, with $175 million in annual run-rate cost synergies anticipated by year three. However, the transaction is subject to stockholder and regulatory approvals, with closing expected in Q1 2027, and CRH's pro forma net debt/EBITDA of 2.4x indicates increased leverage.

• · CRH intends to fund the transaction with available cash and committed debt financing.
• · The Boards of Directors of both companies have unanimously approved the transaction.
• · Transaction expected to close in Q1 2027, subject to Arcosa stockholder and regulatory approvals.
• · CRH's pro forma FY 2026E Net Debt / Adjusted EBITDA is 2.4x.
• · Arcosa serves 13 of the 50 largest U.S. MSAs across Texas, New Jersey, Arizona, Florida, and Tennessee.
• · Arcosa's Engineered Structures business is a top three manufacturer of critical infrastructure products in the energy transmission market.
• · CRH is a member of the S&P 500 Index with 83,000 people across 4,000 locations.

22-06-2026

Ligand Pharmaceuticals announced a proposed offering of $550.0 million aggregate principal amount of convertible senior notes due 2031, with an additional option to purchase $82.5 million, in a private placement to qualified institutional buyers. The company will use up to $75 million of net proceeds to repurchase shares, pay for convertible note hedge transactions, and pursue general corporate purposes including its previously announced Xoma Royalty Corporation acquisition. The transaction is intended to enhance financial flexibility and reduce potential dilution, though the separate warrant transactions could have a dilutive effect if Ligand's stock price exceeds the warrant strike price.

• · The notes mature on September 15, 2031, unless earlier converted, redeemed or repurchased.
• · Interest will be payable semiannually on March 15 and September 15, beginning March 15, 2027.
• · Upon conversion, Ligand will pay cash up to the principal amount and may settle the excess in cash, shares, or a combination.
• · The repurchases are expected to be at the last reported price per share on the pricing date.
• · Option counterparties may engage in derivative transactions that could affect the market price of Ligand's common stock or the notes.
• · The notes and warrants are not registered under the Securities Act and are offered only to qualified institutional buyers under Rule 144A.

22-06-2026

On June 17, 2026, Apogee Therapeutics, Inc. entered into an antibody discovery agreement and a license agreement with Paragon Therapeutics, Inc. to develop antibodies targeting IL-31R. Under the license agreement, Apogee will pay up to $23.25 million in development, clinical, and regulatory milestones, plus low-single digit royalties on net sales. The company is solely responsible for development, manufacturing, and commercialization costs. No negative or flat performance data is reported, as this is a forward-looking strategic agreement.

• · The IL-31R Discovery Agreement includes a monthly research fee for Paragon, subject to adjustment.
• · Apogee may terminate the IL-31R Discovery Agreement with 30 days’ notice; Paragon may terminate if the research program is suspended for four consecutive months.
• · The IL-31R License Agreement grants an exclusive, worldwide, royalty-bearing, sublicensable license for IL-31R antibodies, but Paragon retains non-exclusive rights for multispecific antibodies.
• · Apogee has a right of first negotiation for certain multispecific antibodies developed by Paragon.
• · Royalties are due on a product-by-product and country-by-country basis until the later of 12 years after first commercial sale or expiration of last valid patent claim.
• · Apogee can terminate the license agreement on a country-by-country or product-by-product basis with 60 days’ notice; material breach cure period is 90 days (30 days for payment failure).

22-06-2026

CRH (NYSE: CRH) has agreed to acquire 100% of Arcosa, Inc. (NYSE: ACA) for $150 per share in an all-cash transaction valued at approximately $8.5 billion enterprise value, representing an 11.5x multiple on 2026E Adjusted EBITDA. The deal is expected to be accretive to earnings, margin, and cash flow within 12 months post-completion, with $175 million in annual run-rate cost synergies anticipated by year three. However, the transaction is subject to Arcosa stockholder and regulatory approvals, with a targeted close in Q1 2027, and CRH's pro forma net debt/EBITDA of 2.4x indicates a moderate leverage increase.

• · Arcosa's Construction Products business has 109 quarries and yards, nine asphalt plants, 19 terminals, and approximately 35 million tons of 2025 aggregates shipments.
• · Arcosa's Engineered Structures business is a top three manufacturer of critical infrastructure products for the energy transmission market.
• · The combined entity will have over 265 million tons of annualized aggregates production.
• · CRH has 83,000 people across 4,000 locations and is a member of the S&P 500 Index.
• · The transaction is expected to close in Q1 2027, subject to Arcosa stockholder and regulatory approvals.
• · CRH intends to fund the transaction with available cash and committed debt financing.
• · J.P. Morgan and Morgan Stanley are providing CRH with committed bridge financing.
• · Arcosa serves 13 of the 50 largest U.S. MSAs across Texas, New Jersey, Arizona, Florida, and Tennessee.

22-06-2026

Klotho Neurosciences, Inc. reported its Q3 FY25 financial results, with revenue increasing 12.1% year-over-year to $45.2 million, driven by strong sales in its core neurology product line. However, net income declined 8.5% to $8.3 million due to higher R&D expenses and a 14.3% rise in SG&A costs, resulting in a mixed performance overall.

• · R&D expenses increased from $12.0M to $14.5M YoY, a 20.8% rise
• · SG&A expenses rose from $9.8M to $11.2M YoY, a 14.3% increase
• · Gross margin improved from 58.2% to 59.5% YoY
• · Cash position decreased from $32.0M to $28.5M quarter-over-quarter
• · Patient enrollment in the NeuroStim 3000 clinical trial reached 1,200 as of end of quarter

22-06-2026

First Tracks Biotherapeutics (TRAX) entered into a sublease agreement with AnaptysBio on June 15, 2026, for approximately 45,057 rentable square feet at 10770 Wateridge Circle, San Diego, CA. The sublease has a 12-month initial term with an option to extend until April 4, 2028, and the company can terminate with three months' notice. The company is responsible for monthly Basic Rent plus Additional Rent under the Master Lease, but AnaptysBio remains primarily liable for the Master Lease obligations.

• · The sublease is subordinate to the Master Lease and will terminate immediately if AnaptysBio's tenancy under the Master Lease ends.
• · AnaptysBio cannot surrender or terminate the Master Lease before its scheduled expiration without the Company's consent (except for its own Termination Option).
• · The Company has the right to terminate the sublease at any time with at least three months' prior written notice.
• · The sublease commenced on June 15, 2026, and the filing was made on June 22, 2026.

22-06-2026

Adaptive Biotechnologies priced an upsized $300M 0% convertible senior notes offering due 2031, increased from $250M, with net proceeds of ~$290.8M. The company plans to use ~$22.3M for capped call transactions, ~$25M to repurchase 1,451,800 shares of common stock, and the remainder to repay the OrbiMed Purchase Agreement and fund general corporate purposes and MRD initiatives. However, the offering includes potential dilution if the stock price exceeds the $34.44 cap price, and the initial conversion price of $24.11 represents a 40% premium over the June 16 closing price of $17.22.

• · The notes mature on July 1, 2031, unless earlier repurchased, redeemed or converted.
• · Noteholders can convert only before April 1, 2031 upon certain events; after that date, conversion is at any time until close of business on the second scheduled trading day before maturity.
• · Redemption is allowed on or after July 1, 2029 if stock price exceeds 130% of conversion price for a specified period.
• · If aggregate principal outstanding is less than 15% of initial issuance, notes can be redeemed in whole.
• · In case of a fundamental change, noteholders may require repurchase at principal plus accrued interest.
• · The capped call transactions have a cap price of $34.44 per share (100% premium over $17.22).
• · If market price exceeds cap price, dilution will occur.
• · Option counterparties may engage in derivative transactions that could affect stock price and conversion terms.

22-06-2026

On June 15, 2026, Cheetah Net Supply Chain Service Inc. entered into a Securities Purchase Agreement with its CEO, Interim CFO, director, and Chairman Huan Liu, issuing 200,000 shares of Class B common stock at $2.00 per share for aggregate gross proceeds of $400,000. The transaction was conducted as a private placement exempt from registration under Regulation S and Section 4(a)(2)/Rule 506(b).

• · The issuance was made as a private placement exempt from registration under Regulation S and/or Section 4(a)(2) / Rule 506(b) of the Securities Act.
• · The Purchaser represented that the shares were acquired for investment purposes and not for distribution.
• · No general solicitation or advertising was used in the offer and sale.
• · The shares are restricted securities.
• · Company is an emerging growth company as defined under the JOBS Act.

22-06-2026

Cohen & Company Inc. (COHN) disclosed that its indirect subsidiary, Cohen & Company Securities, LLC, entered into a Fourth Amendment to its existing Loan Agreement with Byline Bank on June 18, 2026. The amendment extends the maturity date to June 2028, updates definitions, and introduces a new Excess Net Capital covenant requiring at least $30 million (with a two-business-day cure period), while also increasing the required Tangible Net Worth from $70 million to $80 million effective March 31, 2027. No financial results or period-over-period comparisons are provided in this filing.

• · The amendment replaces certain definitions to reflect the Borrower's and its parent entity's current names.
• · Failure to maintain Excess Net Capital of at least $30 million constitutes an event of default, with a two-business-day cure period.
• · The maturity date and final loan availability date were extended from June 18, 2026 to June 18, 2028.
• · The required Tangible Net Worth increases from $70 million to $80 million effective after March 31, 2027.

22-06-2026

On June 15, 2026, AnaptysBio subleased approximately 45,057 rentable square feet of its San Diego headquarters to First Tracks Biotherapeutics for an initial 12-month term, with First Tracks paying monthly rent equal to the basic rent and additional rent under the master lease. However, AnaptysBio remains primarily liable for all rent and obligations under the master lease, and the sublease terminates if the company's tenancy ends for any reason. The filing discloses a material sublease agreement but includes no financial terms beyond the pass-through of master lease rent obligations.

• · Sublease term commenced June 15, 2026 and runs for 12 months.
• · First Tracks has a renewal option from end of initial term until earlier of April 4, 2028 or 12 months from renewal start, with 3 months' notice.
• · First Tracks can terminate the sublease at any time with at least 3 months' written notice.
• · The sublease is subordinate to the existing master lease dated May 4, 2020 (as amended April 5, 2021).
• · AnaptysBio cannot surrender or terminate the master lease without First Tracks' consent (except via the master lease's Termination Option).

22-06-2026

Pluri Inc. entered into an Advance Subscription Agreement with Chutzpah Holdings LP, beneficially owned by Chairman Alexandre Weinstein, receiving an advance of $1,250,000 for working capital. The advance is intended to be credited toward a future offering to be consummated by August 14, 2026, but if not, the unapplied amount will be applied to other securities purchases. Additionally, at the 2026 Annual Meeting, director Eitan Ajchenbaum was not re-elected (2,830,098 for vs. 3,668,436 against), and Doron Shorrer was appointed to fill the vacancy, serving as Audit Committee Chair and Investment Committee sole member.

• · The Advance Amount of $1,250,000 was received on June 16, 2026.
• · The Offering must be consummated on or before August 14, 2026, or the unapplied advance will be applied to other securities purchases.
• · Eitan Ajchenbaum received 2,830,098 votes for and 3,668,436 votes against, failing re-election.
• · Doron Shorrer, age 73, is a founder of the Company and previously served as a director until June 2022.
• · Mr. Shorrer holds a B.A. in Economics and Accounting and an M.B.A. in Finance and Banking from Hebrew University and is a CPA in Israel.
• · The ratification of PwC as auditor received 7,558,826 votes for, 20,364 against, and 2,007 abstentions.
• · The Company's common shares trade on Nasdaq under symbol PLUR.

22-06-2026

Genvor Inc entered into a side letter agreement with Evergreen Capital Management LLC on June 17, 2026, amending the prior securities purchase agreement. The amendment deletes Evergreen's registration rights, increases warrant coverage from 600,000 to up to 1,200,000 shares, and accelerates funding of the second and third tranches, providing the company with $333,334 in gross proceeds on the effective date. However, the fourth tranche of $166,667 is now solely at Evergreen's option, introducing uncertainty about full funding of the $800,000 note.

• · The warrant has a five-year term and an exercise price of $1.00 per share, subject to adjustment.
• · After the six-month anniversary of issuance, if the market price exceeds the exercise price and the warrant shares are not registered, Evergreen may exercise on a cashless basis.
• · The fourth tranche option expires on the maturity date of the note.
• · Evergreen retains $10,000 from each tranche for legal fees and closing costs.

22-06-2026

ARES CAPITAL CORP (ARCC), through its subsidiary ARCC FB FUNDING LLC, entered into the Tenth Amendment to its Revolving Credit and Security Agreement with BNP Paribas as administrative agent and other lenders, dated June 18, 2026. The amendment adjusts advance rates for certain collateral loan categories (including First Lien, Second Lien, and First Lien Last Out loans) based on leverage thresholds and loan class, with no new credit commitments or changes to the uncommitted nature of the facility. The filing does not disclose any specific financial amounts, changes in total facility size, or any defaults or adverse events; however, the amendment reflects continued access to secured financing for ARCC's portfolio.

• · The Amendment updates advance rates for three loan types (First Lien, First Lien Last Out, Second Lien) across three loan classes (Class 1, 2, 3), with rates ranging from 30% to 65%.
• · First Lien Loans that are Recurring Revenue Loans have no fixed advance rate and are assigned by the Administrative Agent in its sole discretion.
• · First Lien Last Out Loans with a First Out Leverage greater than 2.00:1.00 are assigned the lower advance rates applicable to Second Lien Loans of the same class.
• · First Lien Loans with a Senior Net Leverage Ratio exceeding the First Lien Senior Leverage Cut-Off receive a blended rate, with portions above the cut-off treated similarly to Second Lien Loans up to a cap, and portions above the cap assigned a 0% advance rate.
• · No new lenders, changes in aggregate commitment amounts, or specific financial impacts (e.g., interest rates, fees) are disclosed in the filing.
• · Representations and warranties state no Default, Event of Default, Potential Servicer Removal Event, or Servicer Removal Event is continuing as of the amendment date.
• · The facility remains uncommitted—all advances are discretionary on the part of the lenders.

22-06-2026

HIVE Digital Technologies, through its subsidiary BUZZ HPC, announced a landmark USD $220 million three-year sovereign AI GPU contract with Bell AI Fabric and Cohere Inc. The deal involves deploying 2,304 NVIDIA Grace Blackwell GPUs in a Canadian data centre, with expected go-live in late 2026 to early 2027. While the contract adds approximately $70 million in annual recurring revenue (ARR) to the current $35 million ARR, the deployment timeline is over a year away and the company is funding the GPU purchase through a recent $115 million convertible note financing, adding leverage.

• · The deployment will be located at Bell's facility in Merritt, British Columbia.
• · HIVE is funding the GPU purchase using a portion of proceeds from its USD $115 million convertible note financing completed in April 2026.
• · Hypertec is providing bespoke GPU server solutions including hardware procurement, system integration, installation, commissioning, and OEM support.
• · The contract is a three-year term with total value of approximately USD $220 million.
• · Expected go-live is late 2026 to early 2027, meaning revenue recognition is deferred for over a year.
• · Cohere has raised approximately $1.6B USD from investors including AMD Ventures, Salesforce Ventures, Oracle, and Cisco.

22-06-2026

GameSquare Holdings, Inc. (NASDAQ:GAME) announced that at its 2026 Annual Meeting of Stockholders held on June 18, 2026, stockholders approved all four proposals: election of two Class II directors, ratification of Kreston GTA as auditor, advisory approval of executive compensation, and approval of a merger agreement to restate the Certificate of Incorporation. CEO Justin Kenna highlighted that the approvals enable a streamlined corporate structure for faster decision-making and support the company's strategic growth plan. No specific financial results or performance metrics were disclosed in this filing.

• · Annual Meeting held on June 18, 2026.
• · Stockholders approved election of two Class II directors, ratification of Kreston GTA as auditor, advisory vote on executive compensation, and merger agreement to restate Certificate of Incorporation.
• · Official voting results will be filed with the SEC and available at www.sec.gov.
• · GameSquare operates one of the largest gaming media networks in North America, focusing on Gen Z, Gen Alpha, and Millennial audiences.

22-06-2026

Blue Owl Technology Finance Corp. entered into a Fourth Amendment to its Amended and Restated Senior Secured Credit Agreement, dated June 16, 2026, with Truist Bank as Administrative Agent. The amendment modifies existing credit terms and includes the joinder of new lenders as well as reductions of certain revolving commitments, all effective upon fulfillment of specified conditions. No specific financial figures or period-over-period performance data are provided in this filing.

• · The Fourth Amendment was dated June 16, 2026, and filed on June 22, 2026.
• · Existing credit agreement was originally dated November 15, 2022, with prior amendments in September 2023, June 2024, and December 2024.
• · The amendment includes joinder of new lenders and reduction of revolving commitments for certain existing lenders.
• · Borrower represented that no Default or Event of Default occurred as of the effective date.
• · The amendment requires prepayment and re-borrowing of revolving loans to reallocate lender commitments.

22-06-2026

BuzzFeed, Inc. entered into two share purchase agreements on June 17, 2026, selling an aggregate of 4,216,999 shares of Class A common stock at $1.44 per share. The company received approximately $5.8 million from the sale of 4,000,000 shares to Allen Family Digital, LLC, and an additional amount from the sale of 216,999 shares to individual purchasers. The transactions were exempt from registration under Section 4(a)(2) of the Securities Act.

• · The purchase price of $1.44 per share was the closing price on June 15, 2026.
• · The shares were issued on June 18, 2026.
• · The transactions were exempt from registration under Section 4(a)(2) of the Securities Act.
• · The board of directors approved both agreements.

22-06-2026

Nexentis Technologies Inc. (N2OFF) entered into a securities purchase agreement on June 22, 2026, for a registered direct offering of 410,998 shares at $7.056 per share, alongside a private placement of 410,998 warrants with a 5-year term and an exercise price of $7.056 per share. The offerings are expected to close on June 24, 2026, with aggregate gross proceeds of approximately $2.9 million. The company must file a resale registration statement within 30 days of closing and have it declared effective within 60 days.

• · The offering price represented a premium to the Nasdaq Minimum Price under Listing Rule 5635(d).
• · Warrants may be exercised on a cashless basis if no effective registration statement registers the underlying shares.
• · The resale registration statement must be filed with the SEC within 30 days of the closing date and declared effective within 60 days.
• · The company is an emerging growth company and has not elected to use the extended transition period for complying with new financial accounting standards.

22-06-2026

Algorhythm Holdings, Inc. (RIME) disclosed it failed to pay a $1,500,000 payment due May 2, 2026 on a $1,750,000 promissory note issued to SemiCab, Inc. in connection with an equity purchase agreement. The company entered a second forbearance agreement on June 16, 2026, extending the forbearance period to July 16, 2026, after a similar forbearance expired on June 16, 2026. The repeated defaults and short extension suggest ongoing liquidity strain.

• · The initial $1,500,000 payment under the promissory note was due on May 2, 2026 but has not been made as of the filing.
• · A first forbearance agreement dated May 9, 2026 provided a forbearance period through June 16, 2026.
• · The second forbearance agreement (June 16, 2026) extends the forbearance period to July 16, 2026, only one additional month.
• · The remaining $250,000 payment is still due on November 2, 2026.

22-06-2026

Rush Enterprises, Inc. (RUSHB) announced a material amendment to its Canadian floor plan credit agreement, increasing the total loan commitment from $171.7 million CAD to $194.7 million CAD, effective June 15, 2026. The amendment, entered into by subsidiary Rush Truck Centres of Canada Limited and guaranteed by the Company, reflects expanded financing capacity. No negative or flat metrics are present in this filing.

• · The Fourth Amendment was effective June 15, 2026, and filed on June 22, 2026.
• · The amendment modifies the Amended and Restated BMO Wholesale Financing and Security Agreement originally dated July 15, 2022.
• · Rush Enterprises, Inc. acts as guarantor for the credit agreement.

22-06-2026

Stellus Private Credit BDC entered into a new investment advisory agreement with Stellus Private BDC Advisor, LLC on June 22, 2026, following shareholder approval on June 16, 2026. The new agreement is identical to the prior agreement in terms of fees and structures, but has a new two-year initial term starting June 22, 2026. The agreement became effective upon the acquisition of Stellus Capital Management, LLC by Ridgepost Capital, LLC, which resulted in a change of control of the advisor; Ridgepost Capital is a publicly listed company on the NYSE.

• · The new advisory agreement was approved by shareholders on June 16, 2026.
• · The base management fee and incentive fee structures are unchanged from the prior advisory agreement dated January 7, 2022.
• · The new agreement has an initial two-year term from June 22, 2026, renewable annually thereafter subject to board and disinterested director approval.
• · The agreement became effective upon the closing of the acquisition of Stellus Capital Management, LLC by Ridgepost Capital, LLC, which occurred on June 22, 2026.
• · Ridgepost Capital, Inc., the parent of Ridgepost Capital, LLC, is a reporting company listed on the NYSE.

22-06-2026

Stellus Capital Investment Corporation (SCM) entered into a new investment advisory agreement with Stellus Capital Management, LLC on June 22, 2026, following stockholder approval on June 16, 2026. The new agreement is identical in terms to the prior agreement from 2012, including fee structures, and became effective upon the closing of the acquisition of the Advisor by Ridgepost Capital, LLC. The agreement has an initial two-year term and renews annually subject to board and independent director approval.

• · The new advisory agreement was approved by stockholders on June 16, 2026.
• · The prior advisory agreement was dated October 26, 2012.
• · The new agreement has an initial two-year term from June 22, 2026, renewable annually.
• · Renewal requires approval by the board or a majority of outstanding voting securities, plus a majority of independent directors.
• · The change in control of the Advisor resulted from the acquisition by Ridgepost Capital, LLC, completed on June 22, 2026.
• · Ridgepost Capital, Inc. is a reporting company listed on the New York Stock Exchange.

22-06-2026

NeoGenomics, Inc. entered into a capped call option transaction with a dealer to hedge the conversion of its $275 million (plus up to $41.25 million additional) 2032 Convertible Senior Notes. The transaction is designed to reduce potential dilution upon conversion, with a strike price and cap price set per the offering memorandum. The filing details the terms of the ISDA-based confirmation, including automatic exercise provisions and settlement mechanics.

• · The capped call transaction covers the number of Convertible Notes initially issued (each $1,000 principal) and any additional notes purchased by initial purchasers.
• · The option style is 'Modified American' with automatic exercise on or after the Free Convertibility Date (April 1, 2032) and on the Expiration Date (July 1, 2032).
• · The transaction includes provisions for early conversions, repurchase events, and settlement methods (Net Share, Cash, or Combination Settlement).
• · The confirmation is governed by a 2002 ISDA Master Agreement with New York law and includes cross-default provisions for the dealer.

22-06-2026

Graybar Electric Company, Inc. amended its Prudential Shelf Agreement on June 17, 2026, extending the issuance period to August 2, 2029. No other material terms were changed, and no financial amounts or performance metrics were disclosed in this filing.

• · The amendment extends the issuance period under the Prudential Shelf Agreement to August 2, 2029.
• · Other material terms of the agreement remain unchanged.
• · The full text of the amendment will be filed as an exhibit to the Company's Quarterly Report on Form 10-Q for the quarter ending June 30, 2026.

22-06-2026

Lionheart Holdings (CUBWU) filed an 8-K on June 22, 2026, reporting that shareholders approved an extension of the company's 'Completion Window' from 24 months to 33 months following its IPO. The amendment was passed as a special resolution at an extraordinary general meeting held on June 18, 2026, and is effective immediately.

• · The original Completion Window was 24 months post-IPO; the amended version extends it to 33 months.
• · The extraordinary general meeting was held at 200 W Cypress Creek Road, Suite 500, Fort Lauderdale, Florida 33309.
• · The amendment was approved as a special resolution, requiring a higher threshold than ordinary resolutions.

22-06-2026

Infinity Natural Resources, LLC entered into a Fifth Amendment to its Credit Agreement with Citibank, N.A. as Administrative Agent, amending definitions and financial covenants, including the addition of a Senior Secured Leverage Ratio and revised Restricted Payment Conditions. The amendment allows for increased restricted payments up to $30 million annually under certain leverage and liquidity conditions, and permits additional restricted payments through December 31, 2026, provided no loans are outstanding and unrestricted cash exceeds $10 million. The amendment became effective June 22, 2026, with no defaults continuing.

• · The amendment adds a new definition for Senior Secured Leverage Ratio, calculated as Consolidated Total Debt secured by a Lien divided by Consolidated EBITDAX.
• · Restricted Payment Conditions now include two alternative tests: (a) Available Commitment ≥20% of Total Commitment, Consolidated Total Net Leverage Ratio ≤2.00x, and Distributable Free Cash Flow ≥0; or (b) Available Commitment ≥20% and Consolidated Total Net Leverage Ratio ≤1.50x.
• · Under Section 10.6(p), Restricted Payments up to $30 million per fiscal year require Available Commitment ≥25% of Total Commitment and Senior Secured Leverage Ratio ≤1.75x.
• · New clause (q) permits additional Restricted Payments through December 31, 2026, with conditions: no outstanding Loans, Unrestricted Cash >$10 million, and no Default/Event of Default/Loan Limit Deficiency.
• · The amendment reaffirms all existing Credit Documents and security interests without impairment.

22-06-2026

Oxbridge Re Holdings Limited entered into an At-the-Market Sales Agreement with Chardan Capital Markets LLC to sell up to $1,678,301 of ordinary shares. The agreement replaces a prior sales agreement with Maxim Group LLC that was terminated on June 20, 2026. Proceeds will be used for general corporate purposes and reinsurance operations.

• · The Sales Agreement replaced a prior agreement with Maxim Group LLC dated July 9, 2025, which was terminated on June 20, 2026.
• · The company will reimburse the Sales Agent for legal fees up to $20,000.
• · Sales may be made directly on the Nasdaq Capital Market as 'at-the-market' offerings.
• · The company is not obligated to make any sales under the agreement.
• · Proceeds will be invested in short-term, investment grade instruments or held as cash pending use.

22-06-2026

SurgePays, Inc. has entered into a Secured Note Purchase Agreement with an accredited investor, involving the issuance of a secured promissory note convertible into common stock. The note is secured by a junior perfected security interest in all assets of the company and its subsidiaries, and is guaranteed by Torch Wireless. The agreement is exempt from registration under Section 4(a)(2) of the Securities Act and Rule 506(b), and the specific principal amount and purchase price are not disclosed in the filing.

• · The note is convertible into shares of common stock with a par value of $0.001 per share.
• · The note is secured by a junior perfected security interest in all existing and future assets of the Note Parties, subject to customary 'excluded property' provisions.
• · The note is guaranteed by Torch Wireless.
• · The agreement relies on exemptions from securities registration under Section 4(a)(2) of the 1933 Act and Rule 506(b).
• · The specific principal amount and purchase price are not disclosed in the filing.

22-06-2026

NorthWestern Energy Group, Inc. (NWE) subsidiary NWE Public Service issued $150 million in South Dakota First Mortgage Bonds due June 15, 2036, with a 5.51% interest rate. The bonds were issued in a private placement exempt from SEC registration and rank equally with existing secured debt. Proceeds will support general corporate purposes, but no specific use or impact on existing debt levels was disclosed.

• · The SD Bonds were issued in a transaction exempt from the registration requirements of the Securities Act of 1933.
• · The bonds have a make-whole redemption provision allowing NWE Public Service to redeem them at any time prior to maturity.
• · The SD Indenture includes customary events of default, including payment defaults and bankruptcy-related events.
• · Upon an event of default, the principal plus accrued interest may be declared immediately due and payable, and the trustee may take possession of and sell mortgaged property.
• · The filing does not disclose the intended use of proceeds or any impact on NWE's existing debt or credit ratings.

22-06-2026

Rayonier Advanced Materials (RYAM) announced the appointment of Daniel M. Krawczyk as CEO and President, effective immediately, and he will also join the Board. The company continues its comprehensive review of strategic alternatives with Morgan Stanley, while Krawczyk's appointment sharpens focus on the business and strategic review. RYAM generated $1.5 billion of revenue in 2025, and Krawczyk brings experience leading a $1.3 billion portfolio and executing over $2 billion in M&A, but the filing does not provide current financial performance or any negative/declining metrics, indicating a neutral to positive outlook pending the strategic review outcome.

• · The prior interim Office of the Chief Executive Officer—comprising Marcus J. Moeltner, Michael Osborne, Christian Ribeyrolle, and R. Colby Slaughter—has been disbanded; these executives will continue in their prior roles under Krawczyk.
• · Krawczyk previously served as President of Huber Engineered Materials, leading a $1.3 billion global industrial and specialty chemicals portfolio and executing over $2 billion in M&A over the past decade.
• · No conclusions have been reached regarding the strategic alternatives review, and the appointment should not be viewed as signaling any particular outcome.

22-06-2026

Sable Offshore Corp. (SOC) announced an amendment to its Senior Secured Term Loan, extending the maturity date to July 24, 2026, and a limited waiver of P&A Financial Security obligations under its PSA with Exxon until December 22, 2028. The company agreed to pay a $30.0 million amendment fee to Exxon, while Exxon waived the $25.0 million minimum liquidity covenant. Sable intends to reduce the proposed new senior secured term loan to up to $775.0 million and pursue additional unsecured capital markets solutions, but there are no assurances of successful financing.

• · The amendment extends the Senior Secured Term Loan maturity to the earlier of July 24, 2026, or acceleration following an Event of Default.
• · The limited waiver of P&A Financial Security obligations runs until the earlier of December 22, 2028, refinancing of the new loan, or an Event of Default.
• · The company intends to use proceeds from the new loan and unsecured capital markets solutions to repay the existing Senior Secured Term Loan and pay transaction fees.
• · Closing of the New Senior Secured Term Loan is subject to market conditions, negotiation of definitive documents, and customary closing conditions.
• · The company's operations are focused on the Santa Ynez Unit in federal waters offshore California.

22-06-2026

NutriBand Inc. (NTRBW) amended its existing $5,000,000 credit line facility on June 1, 2026, extending the maturity to July 1, 2029 (from the prior July 13, 2026 expiration) and maintaining a 7% annual interest rate. The facility is non-convertible and proceeds are restricted to funding FDA submission and commercial manufacturing costs with Kindeva Drug Delivery for its lead product AVERSA™ Fentanyl. No drawdowns are permitted until work on the NDA filing with Kindeva has commenced.

• · The credit line is non-convertible; the lender cannot convert outstanding amounts into common stock.
• · Advances can only be drawn after the Company has commenced work with Kindeva directly related to filing the NDA with the FDA.
• · Proceeds are primarily for up-front manufacturing costs with Kindeva.
• · Interest payments are due within 30 days of each calendar year-end, starting June 1, 2026.
• · The facility allows repayment and reborrowing without penalty.
• · Events of default include failure to timely file SEC periodic reports and a Material Adverse Change clause.
• · The lender is based in Portugal (Rua das Ladeiras 5, Porto Santo).

22-06-2026

Booz Allen Hamilton has agreed to acquire Ultra I&C Mission Solutions (Ultra Mission Solutions) from Advent portfolio company Cobham Ultra Group for $720 million. The acquisition will enhance Booz Allen's defense technology portfolio with mission-critical software, encryption, and edge-compute products. The transaction is expected to close in Q2 of fiscal year 2027 (by September 30, 2026), with Ultra Mission Solutions operating as a wholly owned subsidiary. Booz Allen expects the acquired revenue to grow at a strong double-digit rate with EBITDA margins well above 20%.

• · Ultra Mission Solutions employs approximately 220 people, including roughly 135 specialized engineers, across five U.S. facilities, with headquarters in Austin, Texas.
• · Ultra Mission Solutions operates across three lines of business: Mission Software, Edge Compute, and Encryption Management.
• · The acquisition will enable increased product integration and commercially available solutions through outcomes-based procurement, Foreign Military Sales (FMS), and other go-to-market channels.
• · Advent has invested more than $15 billion enterprise value across the global defense sector since 2020.
• · Booz Allen expects revenue from this acquisition to grow at a strong double-digit rate for the next several years with EBITDA margins well above 20%.
• · The transaction is subject to customary closing conditions and is expected to close in Q2 of Booz Allen’s fiscal year 2027 (ending September 30, 2026).

22-06-2026

UNFI entered into Amendment No. 5 to its Term Loan Agreement on June 18, 2026, repricing its approximately $371 million outstanding term loan and reducing the applicable margin over SOFR from 4.75% to 4.00%. This amendment lowers the company's interest expense but does not change other material terms of the loan.

• · The amendment was entered into on June 18, 2026, and filed on June 22, 2026.
• · The Term Loan Agreement was originally dated October 22, 2018.
• · The amendment reprices the term loan but leaves all other material terms unchanged.

22-06-2026

Playboy, Inc. (PLBY) announced a definitive agreement to repurchase 16.6 million shares (nearly 15% of outstanding shares) from Fortress Investment Group at a fixed price of $1.05 per share, for total consideration of approximately $17.4 million — a 28% discount to the market value. The company paid $2.0 million at execution and will pay the remaining $15.4 million in three installments through December 31, 2026. The deal is fully backstopped by commitments from Rizvi Traverse and Byborg Enterprises SA. Playboy has reported five consecutive quarters of positive adjusted EBITDA, but the transaction highlights ongoing reliance on cash from operations and backstop commitments to complete the buyout.

• · Five consecutive quarters of positive adjusted EBITDA
• · Fortress agreed not to sell, transfer, or dispose of shares during the agreement term
• · Backstop commitments from Rizvi Traverse and Byborg are pro rata based on current Playboy stockholdings
• · Company may accelerate purchases at any time at its discretion
• · Transaction eliminates risk of 16.6 million shares being sold on the open market

22-06-2026

Boxlight Corp (BOXL) filed a Certificate of Change on June 17, 2026, modifying security holder rights. The filing includes items 3.03, 5.03, and 7.01, indicating material modifications to shareholder rights and a related press release. No specific financial figures or performance metrics were disclosed in this filing.

• · Filing includes items 3.03 (Material Modification to Rights of Security Holders), 5.03 (Amendments to Articles of Incorporation or Bylaws), and 7.01 (Regulation FD Disclosure).
• · The Certificate of Change was filed on June 17, 2026, and the 8-K was filed on June 22, 2026.

22-06-2026

Pacific Oak Strategic Opportunity REIT, Inc. appointed Bradley E. Scher as President, CEO, Chairman of the Board, and Director effective June 18, 2026, through his firm Ocean Ridge Capital Advisors, LLC. The agreement sets monthly compensation of $12,500 (allocated $5,000 for CEO/President services and $7,500 for Chairman/Director services) plus expense reimbursement, with Scher serving as an independent contractor. The filing does not disclose any financial results or performance metrics, so no positive or negative trends can be assessed.

• · Scher will serve as an independent contractor, not an employee, and is not entitled to employee benefits such as vacation pay, sick leave, retirement, or social security.
• · The agreement includes indemnification provisions for Scher and Ocean Ridge, with liability capped at the aggregate compensation received.
• · The Company must maintain D&O insurance including a Side A policy for Scher during the term.
• · Disputes will be resolved through arbitration in New York County under AAA rules.
• · The agreement is governed by New York law.